
Post-Hoc Live

Overview
Post-Hoc Live offers an incisive, behind-the-scenes look into the dynamic world of biopharmaceuticals, drug discovery, and global healthcare policy. Drawing from the expertise of Endpoints' reporters and featuring interviews with leading industry commentators like Derek Lowe and Hannah Kuchler, the podcast provides up-to-the-moment analysis on critical topics such as M&A, regulatory shifts, and the intricate politics influencing drug development and pricing. It caters to industry professionals, investors, and anyone seeking a deep, informed perspective on the scientific, business, and political forces shaping the future of medicine, distinguishing itself through its analytical rigor and direct access to expert insights.
Show Impressions
Estimates only, not verified by show
Est. Podcast Downloads
80
Recent Campaigns
Demographics
Location
Fans by country:
Age Distribution
18-24
12.0%
25-34
28.0%
35-44
26.0%
45-54
18.0%
55-64
11.0%
65-99
5.0%
Income Brackets
$50k-60k
13.0%
$60k-70k
12.0%
$40k-50k
11.0%
$70k-80k
11.0%
$80k-90k
10.0%
$30k-40k
9.0%
$90k-100k
9.0%
$100k-150k
8.0%
$20k-30k
7.0%
$10k-20k
4.0%
$150k-200k
4.0%
$200k-1000k
2.0%
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
Top Advertisers
Top Spenders | Est. Spent | Change | Host Read % | DR % | # of ads | Frequency | Top Shows |
|---|---|---|---|---|---|---|---|
Endpoints News | $83 | -24.0% | 8.1% | 100.0% | 99.0ad units | Core Performer | |
Endpoints News | $11 | 0.0% | 7.7% | 100.0% | 13.0ad units | Core Performer | |
Endpoints News | $3 | -100.0% | 0.0% | 100.0% | 4.0ad units | Core Performer |
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
Ads and Episodes

Record IPOs — with Parabalis and Kailera’s CEOs
0:00 / 0:34Direct Response
R
#1
Run on 1x episode
Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.
Recent Episodes